Infectious keratitis after photorefractive keratectomy

Ophthalmology. 2003 Apr;110(4):743-7. doi: 10.1016/S0161-6420(02)01936-X.

Abstract

Purpose: To elucidate risk factors, microbial culture results, and visual outcomes for infectious keratitis after photorefractive keratectomy (PRK).

Design: Multicenter, retrospective chart review, case report, and literature review.

Methods: The records of 12 patients with infectious keratitis after PRK were reviewed.

Main outcome measures: Causative organism, response to medical treatment, and visual outcome.

Results: Infectious keratitis developed in 13 eyes of 12 patients after PRK. Organisms cultured were Staphylococcus aureus (n = 5), including a bilateral case of methicillin-resistant Staphylococcus aureus; Staphylococcus epidermidis (n = 4); Streptococcus pneumoniae (n = 3); and Streptococcus viridans (n = 1). Four patients manipulated their contact lenses, and 2 patients were exposed to nosocomial organisms while working in a hospital environment. Prophylactic antibiotics used were tobramycin (nine cases), polymyxin B-trimethoprim (three cases), and ciprofloxacin (one case). Final best spectacle-corrected visual acuity ranged from 20/20 to 20/100.

Conclusions: Infectious corneal ulceration is a serious potential complication of PRK. Gram-positive organisms are the most common pathogens. Antibiotic prophylaxis should be broad spectrum and should include gram-positive coverage.

Publication types

  • Case Reports
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Ciprofloxacin / therapeutic use
  • Corneal Ulcer / drug therapy
  • Corneal Ulcer / microbiology*
  • Cross Infection / microbiology
  • Drug Therapy, Combination / therapeutic use
  • Eye Infections, Bacterial* / drug therapy
  • Eye Infections, Bacterial* / etiology
  • Female
  • Humans
  • Lasers, Excimer
  • Methicillin Resistance
  • Photorefractive Keratectomy / adverse effects*
  • Polymyxins / therapeutic use
  • Retrospective Studies
  • Risk Factors
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / etiology
  • Streptococcal Infections* / drug therapy
  • Streptococcal Infections* / etiology
  • Tobramycin / therapeutic use
  • Trimethoprim / therapeutic use
  • Visual Acuity

Substances

  • Polymyxins
  • Ciprofloxacin
  • Trimethoprim
  • Tobramycin